Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI)
Publicly reported company facts and saved market data for Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI), with sources and as-of times. Saved data is not a live quote.
Company profile
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on the development of innovative immunology therapies and the operation of a contract development and manufacturing organization. The Company is developing its NanoAb platform through research collaboration and license arrangements with the Max Planck Society and University Medical Center Göttingen. Scinai also owns Scinai Biopharma Services Ltd., a CDMO providing development and manufacturing services to biotechnology and pharmaceutical companies through facilities in Jerusalem and Yavne, Israel.
Company facts
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Market cap
- $1.7M
- Incorporated in
- Israel
- Company website
- www.scinai.com
- Exchange
- NASDAQ
FennEdge notes
Sessions where SCNI appeared in the daily small-cap recap, newest first: opening gap, day change and the SEC filing or halt stored by the close. Facts with source links.
- #7 top gapper · gap +34.48% · closed +6.03% 6-K Contract Scinai Expands CDMO Business with $5.1 Million Development and Clinical Manufacturing Agreement
- #2 top gapper · gap +40.36% · closed +46.99% SEC filings and news not collected for this session
Saved quote
Saved snapshot, not a real-time quote. Check the market time before relying on it.
- Last reported price
- $0.84
- Reported change
- -31.71%
- Reported volume
- 2,722,520
- Latest market time
Short interest
- Reported short interest
- 19,900 shares
- Settlement date
- Source
- Nasdaq
Exchange-published short interest for the stated settlement date, not a live short position.
Recent daily sessions
The 10 most recent saved daily sessions, through . Daily OHLC and volume; not real-time.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 1.18 | 1.20 | 1.10 | 1.16 | 43,266 | |
| 1.22 | 1.23 | 1.18 | 1.18 | 20,348 | |
| 1.11 | 1.23 | 1.06 | 1.21 | 90,570 | |
| 1.20 | 1.23 | 1.12 | 1.13 | 40,439 | |
| 1.26 | 1.29 | 1.22 | 1.22 | 44,298 | |
| 1.33 | 1.36 | 1.26 | 1.26 | 42,256 | |
| 1.30 | 1.37 | 1.30 | 1.33 | 22,168 | |
| 1.39 | 1.45 | 1.27 | 1.31 | 43,751 | |
| 1.36 | 1.42 | 1.32 | 1.42 | 80,134 | |
| 1.50 | 1.50 | 1.35 | 1.41 | 98,629 |
Research this company
FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.
Sign in to continue